StockData
AbbVie Inc. logo

AbbVie Inc.

ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3089% above fair value
$288.84−6.05 (-2.05%)

Close on Nov 2, 2026Market cap $510.41BP/E 81.6Yield 2.30%

AbbVie Other Eye Care by Quarter

Other Eye Care — Worldwide operational (constant-currency) growth YoY (%) (%)

QuarterlyAnnual

AbbVie Other Eye Care: -10.8% in Q4 2025, down 31.4 pts from a year earlier.

Latest, Q4 2025
-10.8%
Period ended Dec 31, 2025
Change on a year earlier
-31.4 pts
20.6% in Q4 2024
History
18 quarters
Since Q3 2021
Sources
18
Documents cited below

Where the Q4 2025 figure comes from

“|| Other Eye Care | 189 | 105 | 294 | (14.9) | (1.5) | (10.5) | (2.3) | (10.8)”

Source: Form 8-K (abbv-20251231xexhibit991.htm, filed 2026-02-04) ↗

Reported in Form 8-K Key Product Revenues Schedule.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOther Eye Care — Worldwide operational (constant-currency) growth YoY (%) (%)Year on yearSource
Q4 2025Dec 31, 2025-10.8%-31.4 ptsForm 8-K (abbv-20251231xexhibit991.htm, filed 2026-02-04) ↗
Q3 2025Sep 30, 20258.2%+5.4 ptsForm 8-K (abbv-20250930xexhibit991.htm, filed 2025-10-31) ↗
Q2 2025Jun 30, 2025-2.1%-8.8 ptsForm 8-K (abbv-20250630xexhibit991.htm, filed 2025-07-31) ↗
Q1 2025Mar 31, 2025-12.5%-14.0 ptsForm 8-K (abbv-20250331xexhibit991.htm, filed 2025-04-25) ↗
Q4 2024Dec 31, 202420.6%+18.2 ptsForm 8-K (abbv-20241231xexhibit991.htm, filed 2025-01-31) ↗
Q3 2024Sep 30, 20242.8%-11.4 ptsForm 8-K (abbv-20240930xexhibit991.htm, filed 2024-10-30) ↗
Q2 2024Jun 30, 20246.7%+5.7 ptsForm 8-K (abbv-20240630xexhibit991.htm, filed 2024-07-25) ↗
Q1 2024Mar 31, 20241.5%-18.3 ptsForm 8-K (abbv-20240331xexhibit991.htm, filed 2024-04-26) ↗
Q4 2023Dec 31, 20232.4%+3.8 ptsForm 8-K (abbv-20231231xexhibit991.htm, filed 2024-02-02) ↗
Q3 2023Sep 30, 202314.2%+7.6 ptsForm 8-K (abbv-20230930xexhibit991.htm, filed 2023-10-27) ↗
Q2 2023Jun 30, 20231.0%-12.2 ptsForm 8-K (abbv-20230630xexhibit991.htm, filed 2023-07-27) ↗
Q1 2023Mar 31, 202319.8%+14.7 ptsForm 8-K (abbv-20230331xexhibit991.htm, filed 2023-04-27) ↗
Q4 2022Dec 31, 2022-1.4%-5.6 ptsForm 8-K (abbv-20221231xexhibit991.htm, filed 2023-02-09) ↗
Q3 2022Sep 30, 20226.6%+1.7 ptsForm 8-K (abbv-20220930xexhibit991.htm, filed 2022-10-28) ↗
Q2 2022Jun 30, 202213.2%–Form 8-K (abbv-20220630xexhibit991.htm, filed 2022-07-29) ↗
Q1 2022Mar 31, 20225.1%–Form 8-K (abbv-20220331xexhibit991.htm, filed 2022-04-29) ↗

Cite this data

StockData. (2026). AbbVie Other Eye Care (%), quarterly Q3 2021–Q4 2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/other-eye-ww-op-yoy

See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.